These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 29302804)

  • 1. Serum adipokine levels and associations with patient-reported fatigue in systemic lupus erythematosus.
    Mahieu MA; Ahn GE; Chmiel JS; Dunlop DD; Helenowski IB; Semanik P; Song J; Yount S; Chang RW; Ramsey-Goldman R
    Rheumatol Int; 2018 Jun; 38(6):1053-1061. PubMed ID: 29302804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adipokine interactions promote the pathogenesis of systemic lupus erythematosus.
    Chougule D; Nadkar M; Venkataraman K; Rajadhyaksha A; Hase N; Jamale T; Kini S; Khadilkar P; Anand V; Madkaikar M; Pradhan V
    Cytokine; 2018 Nov; 111():20-27. PubMed ID: 30098476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatigue, patient reported outcomes, and objective measurement of physical activity in systemic lupus erythematosus.
    Mahieu MA; Ahn GE; Chmiel JS; Dunlop DD; Helenowski IB; Semanik P; Song J; Yount S; Chang RW; Ramsey-Goldman R
    Lupus; 2016 Oct; 25(11):1190-9. PubMed ID: 26869353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Supplemental hydroxychloroquine therapy regulates adipokines in patients with systemic lupus erythematosus with stable disease.
    Wakiya R; Ueeda K; Shimada H; Nakashima S; Kameda T; Miyatake N; Kato M; Miyagi T; Sugihara K; Mizusaki M; Mino R; Kadowaki N; Dobashi H
    Clin Rheumatol; 2022 Nov; 41(11):3345-3353. PubMed ID: 35849246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validity and Reliability of Patient Reported Outcomes Measurement Information System Computerized Adaptive Tests in Systemic Lupus Erythematosus.
    Kasturi S; Szymonifka J; Burket JC; Berman JR; Kirou KA; Levine AB; Sammaritano LR; Mandl LA
    J Rheumatol; 2017 Jul; 44(7):1024-1031. PubMed ID: 28412708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum adipokine levels in patients with systemic lupus erythematosus.
    De Sanctis JB; Zabaleta M; Bianco NE; Garmendia JV; Rivas L
    Autoimmunity; 2009 May; 42(4):272-4. PubMed ID: 19811274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of serum macrophage migration inhibitory factor (MIF), adiponectin, and other adipokines as potential markers of proteinuria and renal dysfunction in lupus nephritis: a cross-sectional study.
    Gamez-Nava JI; Diaz-Rizo V; Perez-Guerrero EE; Muñoz-Valle JF; Saldaña-Cruz AM; Fajardo-Robledo NS; Jacobo-Cuevas H; Nava-Valdivia CA; Alcaraz-Lopez MF; Trujillo X; Huerta M; Cardona-Muñoz EG; Gonzalez-Lopez L
    Biomark Res; 2020; 8():55. PubMed ID: 33133605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin resistance and serum levels of adipokines in patients with systemic lupus erythematosus: a systematic review and meta-analysis.
    Kuo CY; Tsai TY; Huang YC
    Lupus; 2020 Aug; 29(9):1078-1084. PubMed ID: 32605528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adipocytokines in systemic lupus erythematosus: relationship to inflammation, insulin resistance and coronary atherosclerosis.
    Chung CP; Long AG; Solus JF; Rho YH; Oeser A; Raggi P; Stein CM
    Lupus; 2009 Aug; 18(9):799-806. PubMed ID: 19578104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High serum leptin and adiponectin levels as biomarkers of disease progression in Egyptian patients with active systemic lupus erythematosus.
    Kamel SM; Abdel Azeem Abd Elazeem MEMI; Mohamed RA; Kamel MM; Abdel Aleem Abdelaleem EA
    Int J Immunopathol Pharmacol; 2023; 37():3946320231154988. PubMed ID: 36718110
    [No Abstract]   [Full Text] [Related]  

  • 11. Leptin and adiponectin in patients with systemic lupus erythematosus: clinical and laboratory correlations.
    Barbosa Vde S; Francescantônio PL; Silva NA
    Rev Bras Reumatol; 2015; 55(2):140-5. PubMed ID: 25440710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adipokines and systemic lupus erythematosus: relationship with metabolic syndrome and cardiovascular disease risk factors.
    Vadacca M; Margiotta D; Rigon A; Cacciapaglia F; Coppolino G; Amoroso A; Afeltra A
    J Rheumatol; 2009 Feb; 36(2):295-7. PubMed ID: 19132788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in quality of life in relation to disease activity in systemic lupus erythematosus: post-hoc analysis of the BLISS-52 Trial.
    Jolly M; Annapureddy N; Arnaud L; Devilliers H
    Lupus; 2019 Dec; 28(14):1628-1639. PubMed ID: 31674267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mendelian randomization analyses reveal no genetic causal effects of major adipokines on systemic lupus erythematosus.
    Duan P; Tian S
    PLoS One; 2024; 19(5):e0301699. PubMed ID: 38805491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adipokines as novel biomarkers in paediatric systemic lupus erythematosus.
    Al M; Ng L; Tyrrell P; Bargman J; Bradley T; Silverman E
    Rheumatology (Oxford); 2009 May; 48(5):497-501. PubMed ID: 19269958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of disease activity on health-related quality of life in systemic lupus erythematosus - a cross-sectional analysis of the Swiss Systemic Lupus Erythematosus Cohort Study (SSCS).
    Chaigne B; Chizzolini C; Perneger T; Trendelenburg M; Huynh-Do U; Dayer E; Stoll T; von Kempis J; Ribi C;
    BMC Immunol; 2017 Mar; 18(1):17. PubMed ID: 28351341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatigue is independently associated with disease activity assessed using the Physician Global Assessment but not the SLEDAI in patients with systemic lupus erythematosus.
    Mertz P; Piga M; Chessa E; Amoura Z; Voll RE; Schwarting A; Maurier F; Blaison G; Bonnotte B; Poindron V; Fiehn C; Lorenz HM; Korganow AS; Sibilia J; Martin T; Arnaud L
    RMD Open; 2022 Sep; 8(2):. PubMed ID: 36123013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations of the Levels of C4d-bearing Reticulocytes and High-avidity Anti-dsDNA Antibodies with Disease Activity in Systemic Lupus Erythematosus.
    Mora C; Medina-Rosas J; Santos AM; Jaimes DA; Arbeláez AM; Romero C; Cortes A; Londono J
    J Rheumatol; 2016 Sep; 43(9):1657-64. PubMed ID: 27134246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging role of adipokines in systemic lupus erythematosus.
    Li HM; Zhang TP; Leng RX; Li XP; Li XM; Liu HR; Ye DQ; Pan HF
    Immunol Res; 2016 Aug; 64(4):820-30. PubMed ID: 27314594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible role of adipokines in systemic lupus erythematosus and rheumatoid arthritis.
    Barbosa Vde S; Rêgo J; Antônio da Silva N
    Rev Bras Reumatol; 2012; 52(2):278-87. PubMed ID: 22460416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.